Radiation Oncology Journal

Stereotactic body radiation therapy for liver metastases in oligometastatic disease

N. Jaksic, A. Modesto, N. Meillan, A. Bordron, M. Michalet, O. Riou, A. Lisbona, F. Huguet

The Use of MR-Guided Radiation Therapy for Liver Cancer

Sabrina Prime, Joshua P. Schiff, Ali Hosni, Teodor Stanescu, Laura A. Dawson, Lauren E. Henke

Seminars in Radiation Oncology.2024; 34(1): 36. CrossRef

Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging

Julia E. Peltenburg, Ali Hosni, Rana Bahij, Simon Boeke, Pètra M. Braam, William A. Hall, Martijn P.W. Intven, Luca Nicosia, Jan-Jakob Sonke, Marnix Witte, Marlies E. Nowee, Tomas Janssen

Physics and Imaging in Radiation Oncology.2024; 30: 100592. CrossRef

Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations

D. Pezzulla, G. Chiloiro, E. M. Lima, G. Macchia, C. Romano, S. Reina, G. Panza, S. Cilla, A. G. Morganti, F. Cellini, M. A. Gambacorta, F. Deodato

Clinical & Experimental Metastasis.2024; 41(5): 667. CrossRef

Stereotactic Body Radiation therapy for Liver Metastases: Systematic Review and Meta-Analysis With International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines

Ciro Franzese, Alexander V. Louie, Rupesh Kotecha, Zhenwei Zhang, Matthias Guckenberger, Mi-Sook Kim, Alison C. Tree, Ben J. Slotman, Arjun Sahgal, Marta Scorsetti

Practical Radiation Oncology.2024;[Epub] CrossRef

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments

Michael D. Chuong, Mary Ann Clark, Lauren E. Henke, Amar U. Kishan, Lorraine Portelance, Parag J. Parikh, Michael F. Bassetti, Himanshu Nagar, Stephen A. Rosenberg, Minesh P. Mehta, Tamer Refaat, Justin M. Rineer, Adam Smith, Steven Seung, Bassem I. Zaki,

Clinical and Translational Radiation Oncology.2023; 38: 161. CrossRef

A single high-dose irradiation changes accumulation of methotrexate and gene expression levels of SLC and ABC transporters in cancer cells

Kakeru Sato, Tatsuya Seki, Asuka Mizutani, Yuka Muranaka, Shiho Hirota, Kodai Nishi, Kana Yamazaki, Ryuichi Nishii, Takeo Nakanishi, Ikumi Tamai, Keiichi Kawai, Masato Kobayashi

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases

Laura Uder, Marcel Nachbar, Sarah Butzer, Jessica Boldt, Sabrina Baumeister, Michael Bitzer, Alfred Königsrainer, Thomas Seufferlein, Rüdiger Hoffmann, Sergios Gatidis, Konstantin Nikolaou, Daniel Zips, Daniela Thorwarth, Cihan Gani, Simon Boeke

MRI-LINAC: A transformative technology in radiation oncology

John Ng, Fabiana Gregucci, Ryan T. Pennell, Himanshu Nagar, Encouse B. Golden, Jonathan P. S. Knisely, Nicholas J. Sanfilippo, Silvia C. Formenti

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study

Karl Bordeau, Morgan Michalet, Aïcha Keskes, Simon Valdenaire, Pierre Debuire, Marie Cantaloube, Morgane Cabaillé, William Jacot, Roxana Draghici, Sylvain Demontoy, Xavier Quantin, Marc Ychou, Eric Assenat, Thibault Mazard, Ludovic Gauthier, Marie Dupuy,

Journal of Clinical Medicine.2023; 12(3): 1183. CrossRef

The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial

John Nikitas, Lauren M. Smith, Yu Gao, Ting Martin Ma, Ankush Sachdeva, Stephanie M. Yoon, Tommy Jiang, Daniel A. Low, Leslie K. Ballas, Michael L. Steinberg, Minsong Cao, Amar U. Kishan

Radiotherapy and Oncology.2023; 183: 109631. CrossRef

Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience

Giuditta Chiloiro, Luca Boldrini, Angela Romano, Lorenzo Placidi, Huong Elena Tran, Matteo Nardini, Mariangela Massaccesi, Francesco Cellini, Luca Indovina, Maria Antonietta Gambacorta

Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience

Re-I Chin, Joshua P. Schiff, Anirudh Bommireddy, Kylie H. Kang, Neal Andruska, Alexander T. Price, Olga L. Green, Yi Huang, Kevin Korenblat, Parag J Parikh, Jefferey Olsen, Pamela P. Samson, Lauren E. Henke, Hyun Kim, Shahed N. Badiyan

Clinical and Translational Radiation Oncology.2023; 41: 100627. CrossRef

Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review

Colton Ladbury, Arya Amini, Amanda Schwer, An Liu, Terence Williams, Percy Lee

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century

Sara Mheid, Stefan Allen, Sylvia S. W. Ng, William A. Hall, Nina N. Sanford, Todd A. Aguilera, Ahmed M. Elamir, Rana Bahij, Martijn P. W. Intven, Ganesh Radhakrishna, Issa Mohamad, Jeremy De Leon, Hendrick Tan, Shirley Lewis, Cihan Gani, Teo Stanecu, Vero

Degree of reduction in normal liver complication probability from free-breathing to breath-hold liver SBRT: a dose-escalation strategy using radiation dose-volume effect

Deepak Thaper, Hanuman P Yadav, Deepti Sharma, Rose Kamal, Gaganpreet Singh, Arun S. Oinam, Vivek Kumar

Biomedical Physics & Engineering Express.2022; 8(1): 015020. CrossRef

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

P. Hoegen, K. S. Zhang, E. Tonndorf-Martini, F. Weykamp, S. Regnery, P. Naumann, K. Lang, J. Ristau, S. A. Körber, C. Dreher, C. Buchele, C. Rippke, C. K. Renkamp, K. M. Paul, L. König, C. Büsch, J. Krisam, O. Sedlaczek, H.-P. Schlemmer, M. Niyazi, S. Cor

Compact bunker shielding assessment for 1.5 T MR-Linac

Jiwon Sung, Yeonho Choi, Jun Won Kim, Ik Jae Lee, Ho Lee

Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases

Tugce Kutuk, Robert Herrera, Teuta Z. Mustafayev, Gorkem Gungor, Gamze Ugurluer, Banu Atalar, Rupesh Kotecha, Matthew D. Hall, Muni Rubens, Kathryn E. Mittauer, Jessika A. Contreras, James McCulloch, Noah S. Kalman, Diane Alvarez, Tino Romaguera, Alonso N

Advances in Radiation Oncology.2022; 7(6): 100978. CrossRef

MR-guided beam gating: Residual motion, gating efficiency and dose reconstruction for stereotactic treatments of the liver and lung

Stefanie Ehrbar, Sarah Braga Käser, Madalyne Chamberlain, Jérôme Krayenbühl, Lotte Wilke, Michael Mayinger, Helena Garcia Schüler, Matthias Guckenberger, Nicolaus Andratschke, Stephanie Tanadini-Lang

Radiotherapy and Oncology.2022; 174: 101. CrossRef

Que faut-il pour faire de la radiothérapie adaptative « online » ?

G. Delpon, A. Barateau, A. Beneux, I. Bessières, I. Latorzeff, J. Welmant, A. Tallet

Cancer/Radiothérapie.2022; 26(6-7): 794. CrossRef

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Berend J. Slotman, Mary Ann Clark, Enis Özyar, Myungsoo Kim, Jun Itami, Agnès Tallet, Jürgen Debus, Raphael Pfeffer, PierCarlo Gentile, Yukihiro Hama, Nicolaus Andratschke, Olivier Riou, Philip Camilleri, Claus Belka, Magali Quivrin, BoKyong Kim, Anders P

The future of MRI in radiation therapy: Challenges and opportunities for the MR community

Rosie J. Goodburn, Marielle E. P. Philippens, Thierry L. Lefebvre, Aly Khalifa, Tom Bruijnen, Joshua N. Freedman, David E. J. Waddington, Eyesha Younus, Eric Aliotta, Gabriele Meliadò, Teo Stanescu, Wajiha Bano, Ali Fatemi‐Ardekani, Andreas Wetscherek, Uw

Magnetic Resonance in Medicine.2022; 88(6): 2592. CrossRef

Finding Resonance: Using MRI to Improve the Care of Oligometastatic Disease

International Journal of Radiation Oncology*Biology*Physics.2022; 114(5): 936. CrossRef

MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges

Indrin J. Chetty, Anthony J. Doemer, Jennifer L. Dolan, Joshua P. Kim, Justine M. Cunningham, Jadranka Dragovic, Aharon Feldman, Eleanor M. Walker, Mohamed Elshaikh, Khaled Adil, Benjamin Movsas, Parag J. Parikh

International Journal of Radiation Oncology*Biology*Physics.2022; 114(5): 950. CrossRef

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma

Tae Hyun Kim, Sang Myung Woo, Woo Jin Lee, Jung Won Chun, Yu Ri Cho, Bo Hyun Kim, Young-Hwan Koh, Sang Soo Kim, Eun Sang Oh, Do Yeul Lee, Sung Uk Lee, Yang-Gun Suh, Sung Ho Moon, Joong-Won Park

Optimized Adaptive Radiotherapy with Individualized Plan Library for Muscle-Invasive Bladder Cancer Using Internal Target Volume Generation

Yoon Young Jo, Ji Woon Yea, Jaehyeon Park, Se An Oh, Jae Won Park

Assessment of semi-automated stereotactic treatment planning for online adaptive radiotherapy in ethos

Mikel Byrne, Ben Archibald-Heeren, Yunfei Hu, Peter Greer, Suhuai Luo, Trent Aland

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases

Fabian Weykamp, Efthimios Katsigiannopulos, Lars Piskorski, Sebastian Regnery, Philipp Hoegen, Jonas Ristau, C. Katharina Renkamp, Jakob Liermann, Tobias Forster, Kristin Lang, Laila König, Carolin Rippke, Carolin Buchele, Jürgen Debus, Sebastian Klüter,